According to recent researches, the above effects of SMC4 in glioma cells are exerted mainly by activating the TGF β/Smad pathway, along with Smad2/3 phosphorylation and Smad2/3 nuclear translocation (Jiang et al., 2017). This evidence concerns the gene SMAD2 and central nervous system cancer.